/ Print /

PHARMACY BEST PRACTICES

Biomarkers: Top challenges and opportunities in managed careBiomarkers, if used appropriately, could ensure patients receive the appropriate treatment sooner, and that they have better outcomes at reduced costs. But despite the potential and expanding capabilities, barriers to full-fledged use remain.
Four developments helping address the opioid epidemicAs the opioid epidemic continues across the U.S., new treatment programs and guidelines could help reverse the trend.
Top risk factors for opioid use disorder, overdoseIn 2014, nearly 2 million Americans met the diagnostic criteria for a past-year prescription opioid use disorder, and at least 14,000 people died from a prescription opioid overdose. Read about the top drivers and risk factors.
Study: New cholesterol drugs cost 356 times more than genericsA report from the Alliance of Community Health Plans can help get a better sense of how well drugs help patients compared to other treatment options.
How the presidential candidates plan to rein in pharma costs
How the presidential candidates plan to rein in pharma costsFind out where each presidential candidate stands on key issues related to pharmaceutical costs.
Managed care pharmacy survey findings 2016To identify the top managed care pharmacy challenges and what your peers are doing about them, Managed Healthcare Executive, in partnership with Access Market Intelligence and the National Institute of Collaborative Healthcare, conducted its first-ever pharmacy survey during the second quarter of 2016.
HHS makes clinical trials more transparentHHS finalized ClinicalTrial.gov rules encourage healthcare improvement and public benefit by increasing transparency and accountability across the industry.
Medicare Part D patients not taking blood pressure meds correctlyExpert offers specific actions for managed care execs to take
Providers are failing to meet needs of depressed patientsA new study shows that many adults with depression don’t receive treatment, whereas others receive treatments that do not match their level of illness severity.
Insurer expands hep C drug coverageNationwide class action suit spurs new coverage decision for hepatitis C medications.